AQEMIA Announces a Major Multi-year Collaboration of $140 Million With Sanofi
Read moreAqemia is one of "the 21 most promising healthtech startups of 2022, according to top VCs" in Business Insider
Read moreAqemia has been selected to participate to the second edition of the Saclay-Boston Biotech Masterclass organized by Servier and BioLabs France
Read more